These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 4318950)

  • 1. Separation of plaque-type variants of encephalomyocarditis virus by chromatography on calcium phosphate.
    Burness AT
    J Virol; 1967 Apr; 1(2):308-16. PubMed ID: 4318950
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purification of Encephalomyocarditis virus.
    Burness AT
    J Gen Virol; 1969 Sep; 5(2):291-303. PubMed ID: 4310464
    [No Abstract]   [Full Text] [Related]  

  • 3. Encephalomyocarditis virus RNA: variations in polyadenylic acid content and biological activity.
    Hruby DE; Roberts WK
    J Virol; 1976 Aug; 19(2):325-30. PubMed ID: 183008
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative studies of plaque variantes derived from a Florida strain of Venezuelan equine encephlomyelitis virus.
    Pedersen CE; Slocum DR; Robinson DM
    Infect Immun; 1972 Nov; 6(5):779-84. PubMed ID: 4344368
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Electrophoretic separation of two plaque-type variants of encephalomyocarditis virus.
    Breeze DC; Thorne HV
    Nature; 1966 Jun; 210(5040):1080-1. PubMed ID: 4288088
    [No Abstract]   [Full Text] [Related]  

  • 6. Immunization of mice against encephalomyocarditis virus. I. Purification, concentration, and inactivation of encephalomyocarditis virus.
    Bogaerts WJ; Durville-van der Oord
    Infect Immun; 1972 Oct; 6(4):508-12. PubMed ID: 4344026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genomic differences between the diabetogenic and nondiabetogenic variants of encephalomyocarditis virus.
    Bae YS; Eun HM; Yoon JW
    Virology; 1989 May; 170(1):282-7. PubMed ID: 2541543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physical and chemical studies of Mengo virus variants. II. Chromatographic behavior and chemical composition.
    Scraba DG; Hostvedt P; Colter JS
    Can J Biochem; 1969 Feb; 47(2):165-71. PubMed ID: 4304576
    [No Abstract]   [Full Text] [Related]  

  • 9. Chromatographic studies on picornavirus capsid polypeptides.
    Pardoe IU; Burness AT; Clothier FW; Scott EJ
    J Gen Virol; 1975 Jun; 27(3):385-9. PubMed ID: 167119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The genomic RNA of diabetogenic encephalomyocarditis virus: characterization and molecular cloning.
    Jordan GW; Cohen SH; Dandekar S; VandenBrink KM
    Virology; 1987 Jul; 159(1):120-5. PubMed ID: 3037773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Requirement of an adenylic acid-rich segment for the infectivity of encephalomyocarditis virus RNA.
    Goldstein NO; Pardoe IU; Burness AT
    J Gen Virol; 1976 May; 31(2):271-6. PubMed ID: 180245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of viral RNA by electron microscopic in situ hybridization (ISH-EM) in the germinal epithelium of mice infected with encephalomyocarditis (EMC) virus.
    Ueno A; Takeda M; Hirasawa K; Itagaki S; Doi K
    Exp Anim; 1997 Jan; 46(1):79-81. PubMed ID: 9027476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transmissibility of the D variant of encephalomyocarditis virus (EMC-D) in mice.
    Doi C; Takeda M; Hirasawa K; Doi K
    Lab Anim; 1993 Jul; 27(3):222-5. PubMed ID: 8396185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of diabetogenicity attributable to a single amino acid, Ala776, on the polyprotein of encephalomyocarditis virus.
    Bae YS; Yoon JW
    Diabetes; 1993 Mar; 42(3):435-43. PubMed ID: 8381754
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Construction and characterization of two infectious molecular clones of encephalomyocarditis virus.
    Naviaux RK; Cohen SH; Vanden Brink KM; Jordan GW
    J Virol; 1990 Feb; 64(2):913-7. PubMed ID: 2153252
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular identification of diabetogenic viral gene.
    Bae YS; Eun HM; Yoon JW
    Diabetes; 1989 Mar; 38(3):316-20. PubMed ID: 2537245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Further studies on a purification procedure for encephalomyocarditis virus.
    Burness AT; Pardoe IU
    J Gen Virol; 1971 Aug; 12(2):187-90. PubMed ID: 4330790
    [No Abstract]   [Full Text] [Related]  

  • 18. Impairment of EMC viral infectivity by cell-associated ribonuclease.
    Bases RE; Huppert J
    Virology; 1966 Aug; 29(4):596-604. PubMed ID: 4287697
    [No Abstract]   [Full Text] [Related]  

  • 19. Polymyositis and dermatomyositis: no persistence of enterovirus or encephalomyocarditis virus RNA in muscle.
    Jongen PJ; Zoll GJ; Beaumont M; Melchers WJ; van de Putte LB; Galama JM
    Ann Rheum Dis; 1993 Aug; 52(8):575-8. PubMed ID: 8215618
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Encephalomyocarditis virus-induced diabetes mellitus in mice: model of viral pathogenesis.
    Jordan GW; Cohen SH
    Rev Infect Dis; 1987; 9(5):917-24. PubMed ID: 2825321
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.